Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashamalla

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Current Oncology (Toronto, Ont.)|May 27, 2022
Early-Age-Onset Colorectal Cancer in Canada: Evidence, Issues and Calls to ActionMary A De Vera, Sharlene Gill, Shady Ashamalla, et al.
The EPMA Journal|December 25, 2014
Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicineLeonard Berliner, Heinz U Lemke, Eric vanSonnenberg, et al.
Surgery|November 27, 2020
Exploring the perioperative outcomes of a sample of successful adopters of transanal total mesorectal excision (taTME) during the learning phaseAntonio Caycedo-Marulanda, Kara Nadeau, Chris P Verschoor, et al.
Psycho-Oncology|May 22, 2023
Psychosocial well-being during the COVID-19 pandemic among women with and without breast cancerLaura C Pinheiro, Genevieve A Fasano, Anjile An, et al.
Surgical Endoscopy|June 7, 2020
Canadian taTME expert collaboration (CaTaCO) position statementAntonio Caycedo-Marulanda, Carl J Brown, Sami A Chadi, et al.
Neuro-Oncology|February 5, 2019
A low percentage of metastases in deep brain and temporal lobe structuresTed K Yanagihara, J Ricardo McFaline-Figueroa, Nicholas J Giacalone, et al.
Pharmacology Research & Perspectives|August 5, 2022
Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpPEmily M J Fennell, Lucas J Aponte-Collazo, Joshua D Wynn, et al.
ACS Chemical Biology|April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related AnaloguesPaul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
BMJ (Clinical Research Ed.)|September 13, 2022
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trialRebecca C Auer, Michael Ott, Paul Karanicolas, et al.
Cell Death & Disease|June 29, 2026
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Current Oncology (Toronto, Ont.)|May 27, 2022
Early-Age-Onset Colorectal Cancer in Canada: Evidence, Issues and Calls to ActionMary A De Vera, Sharlene Gill, Shady Ashamalla, et al.
The EPMA Journal|December 25, 2014
Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicineLeonard Berliner, Heinz U Lemke, Eric vanSonnenberg, et al.
Surgery|November 27, 2020
Exploring the perioperative outcomes of a sample of successful adopters of transanal total mesorectal excision (taTME) during the learning phaseAntonio Caycedo-Marulanda, Kara Nadeau, Chris P Verschoor, et al.
Psycho-Oncology|May 22, 2023
Psychosocial well-being during the COVID-19 pandemic among women with and without breast cancerLaura C Pinheiro, Genevieve A Fasano, Anjile An, et al.
Surgical Endoscopy|June 7, 2020
Canadian taTME expert collaboration (CaTaCO) position statementAntonio Caycedo-Marulanda, Carl J Brown, Sami A Chadi, et al.
Neuro-Oncology|February 5, 2019
A low percentage of metastases in deep brain and temporal lobe structuresTed K Yanagihara, J Ricardo McFaline-Figueroa, Nicholas J Giacalone, et al.
Pharmacology Research & Perspectives|August 5, 2022
Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpPEmily M J Fennell, Lucas J Aponte-Collazo, Joshua D Wynn, et al.
ACS Chemical Biology|April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related AnaloguesPaul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
BMJ (Clinical Research Ed.)|September 13, 2022
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trialRebecca C Auer, Michael Ott, Paul Karanicolas, et al.
Cell Death & Disease|June 29, 2026
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Pageof 9